David Howard News
-
Thomas Welch knows there’s a better chance he will be fired than retire. So he spent his vacation interning at Merrill Lynch Wealth Management to prepare for a second career to sustain him for the next 40 years.
-
Google Inc.’s Motorola Mobility unit isn’t entitled to the potentially billions of dollars it sought for its patents on technology used throughout the electronics community, a federal judge ruled in a victory for Microsoft Corp.
-
Analysts predict Goldman Sachs Group Inc. will pay $1 billion or more to settle a Securities and Exchange Commission fraud suit that triggered a 26 percent drop in the firm’s stock, Bloomberg News’s Jesse Westbrook and David Scheer report. Extracting such a record-setting penalty may be easier said than done.
-
Microsoft Corp.’s Xbox video-gaming system doesn’t violate the patent rights of Google Inc.’s Motorola Mobility unit, a U.S. trade judge said.
-
Reynolds American Inc. , the second- largest U.S. tobacco company, plans to raise prices on all of its cigarette brands after it increased its share of U.S. smokers in the first quarter.
-
A dozen tobacco companies have gained from a legal loophole that helped them avoid as much as $1.1 billion in U.S. taxes.
-
Microsoft Corp., the world’s biggest software maker, won a U.K. ruling invalidating Motorola Mobility Holdings Inc.’s patent protection for technology synchronizing message statuses across multiple devices.
-
Microsoft Corp., the world’s biggest software maker, asked a U.K. judge to invalidate Motorola Mobility’s European patent protection for synchronizing message statuses across multiple devices.
-
Google Inc. dropped two patents related to industrywide technical specifications from an infringement complaint against Microsoft Corp. at the U.S. International Trade Commission, where Google is seeking to block U.S. imports of Microsoft’s Xbox gaming system.
-
Medicines Co. and Fresenius’s APP Pharmaceuticals Inc. settled litigation over patents for the Angiomax anticoagulant drug, with Medicines agreeing to pay $30 million to license some APP drugs.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page